BI
TENX icon

BVF Inc’s Tenax Therapeutics TENX Stock Holding History

BVF Inc’s Portfolio TENX Stock Details TENX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.94M Hold
339,549
– – 0.13% 41
2026
Q1 		$5.43M Hold
339,549
– – 0.17% 38
2025
Q4 		$4.14M Hold
339,549
– – 0.14% 38
2025
Q3 		$2.58M Hold
339,549
– – 0.1% 41
2025
Q2 		$1.98M Hold
339,549
– – 0.07% 40
2025
Q1 		$2.22M Hold
339,549
– – 0.09% 44
2024
Q4 		$2.1M Hold
339,549
– – 0.07% 49
2024
Q3 		$1.17M Buy
+339,549
New +$1.23M 0.03% 51

Other funds holding TENX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

BVF Inc's TENX Position: Q2 2026 in Review

BVF Inc held its Tenax Therapeutics (TENX) position steady in Q2 2026 at 339,549 shares worth $4.94M. The position accounts for 0.13% of the portfolio, ranked #41.

BVF Inc first reported a position in TENX in Q3 2024 and has held it in 8 quarters since. The position peaked at $5.43M in Q1 2026. 111 funds tracked by Wall St. Rank hold TENX as of Q2 2026.

  • BVF Inc held 339,549 shares of Tenax Therapeutics worth $4.94M as of Q2 2026.
  • BVF Inc left its Tenax Therapeutics share count unchanged in Q2 2026.
  • Tenax Therapeutics made up 0.13% of BVF Inc's portfolio in Q2 2026, its #41 holding.
  • BVF Inc first reported a position in Tenax Therapeutics in Q3 2024 and has held it in 8 quarters since.
  • BVF Inc's Tenax Therapeutics position peaked at $5.43M in Q1 2026.
  • 111 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q2 2026.

Based on BVF Inc's 13F filing for Q2 2026, filed 14 Aug 2026.